Product Information
ACETAMINOPHEN-COD #3 TABLET is a generic product labeled by Elite Laboratories, Inc., priced at $0.2556 per EA under NDC 64850064201. Its NADAC has been published 95 times since Dec 11, 2024.
FDA first approved this application on Sep 10, 2019. Its Orange Book therapeutic-equivalence code is AA.
Strength
300; 30 mg/1; mg/1
Manufacturer
Elite Laboratories, Inc.NDC
64850064201
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACETAMINOPHEN; CODEINE PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA212418FDA Approved
9/10/2019
TE Code
AA
On Market Since
9/10/2019
Pharmacological Classes
Price Statistics
The NADAC for ACETAMINOPHEN-COD #3 TABLET has been published 95 times since Dec 11, 2024, and over the history we have for it it has risen 18.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2556 per EA |
|---|---|
| All-time high | $0.2764 (Nov 12, 2025) |
| All-time low | $0.2090 (Apr 22, 2026) |
| 52-week high | $0.2764 |
| 52-week low | $0.2090 |
| Median price | $0.2489 |
| Average price | $0.2450 |
| Largest weekly change | +8.8% (Dec 18, 2024) |
| Weeks tracked | 95 |
| Tracking since | Dec 11, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 16% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Elite Laboratories, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Acetaminophen and Codeine Phosphate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ACETAMINOPHEN-COD #3 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ACETAMINOPHEN-COD #3 TABLET, manufactured by Elite Laboratories, Inc., is $0.2556 per EA (NDC 64850064201), effective Sep 30, 2026.
How has the price of ACETAMINOPHEN-COD #3 TABLET changed over time?
Over the history we have for it, the NADAC for ACETAMINOPHEN-COD #3 TABLET has risen 18.4%. It has been tracked across 95 weekly CMS publications since Dec 11, 2024.
What are the highest and lowest recorded NADAC prices for ACETAMINOPHEN-COD #3 TABLET?
Since Dec 11, 2024, the NADAC for ACETAMINOPHEN-COD #3 TABLET has ranged from a low of $0.2090 (Apr 22, 2026) to a high of $0.2764 (Nov 12, 2025), with a median of $0.2489 per EA.
Are there cheaper alternatives to ACETAMINOPHEN-COD #3 TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ACETAMINOPHEN-COD #3 TABLET, is $0.2144 per EA — about 16% below ACETAMINOPHEN-COD #3 TABLET.
Who manufactures ACETAMINOPHEN-COD #3 TABLET?
ACETAMINOPHEN-COD #3 TABLET (NDC 64850064201) is labeled by Elite Laboratories, Inc., and CMS classifies it as a generic product.